USFDA Approves Eli Lilly's Mounjaro to Cut Heart Attack, Stroke Risk in High-Risk Type 2 Diabetes Patients Written By sheeba farhat29 Aug 2026 8:06 PM ISTBengaluru: Eli Lilly said on Friday the U.S. FDA has approved its diabetes drug Mounjaro to reduce the chances of heart attack or stroke in adults...
Eli Lilly Launches Foundayo Weight-Loss Pill in UK, First European Market for Oral Treatment Written By sheeba farhat26 Aug 2026 10:30 AM ISTLondon: Eli Lilly has launched its pill, Foundayo, in the UK for weight management and type 2 diabetes, it said on Monday, making Britain the first...
UK First in Europe to Approve Eli Lilly's Foundayo Pill for Weight Management, Type 2 Diabetes Written By MD Bureau12 Aug 2026 10:00 PM ISTBengaluru: Britain's ​medicines regulator on Monday authorised Eli Lilly's pill, Foundayo, ​for weight management and type 2 diabetes, making it the...
Tirzepatide Reduces risk of Heart Attack and hospitalisation due to Infection in Type 2 Diabetes: Study Written By Dr. Kamal Kant Kohli8 Aug 2026 9:00 AM ISTA large U.S. database study found that tirzepatide (Mounjaro) significantly reduced the risk of heart attacks and hospitalization due to infections by...
GLP-1 drug linked to heart benefits for high-risk patients :Study Written By Dr. Kamal Kant Kohli6 Aug 2026 7:30 AM ISTAdding the GLP-1 receptor agonist drug tirzepatide (marketed as Mounjaro) to standard care for patients with type 2 diabetes and heart disease is...
Novo Nordisk Files False Advertising Lawsuit Against Eli Lilly Over Zepbound Ads Written By sheeba farhat22 July 2026 9:27 PM ISTLondon: Novo Nordisk sued rival Eli Lilly in a U.S. federal court ​on Tuesday, accusing the U.S. drugmaker of ​false advertising in claiming its...
Novo Nordisk to Launch Lower-Cost Ozempic Copy Extensior in South Africa Written By sheeba farhat18 July 2026 4:39 PM ISTJohannesburg: Novo Nordisk will launch a more affordable authorised copy of its Ozempic diabetes drug in South Africa later this month, partnering...
Recalls by Dr Reddy's, Torrent Put Spotlight on Quality Standards in India's Semaglutide Market Written By Farhat Nasim10 July 2026 5:28 PM ISTNew Delhi: Three Indian pharmaceutical companies, Dr. Reddy's Laboratories, Torrent Pharmaceuticals and USV, have initiated voluntary recalls of...
Most obesity drugs do not improve quality of life or heart health: Study Written By Dr. Kamal Kant Kohli9 July 2026 7:00 AM ISTDespite substantial weight loss, most obesity drugs such as Wegovy and Mounjaro do not meaningfully improve quality of life and few show...
USFDA Flags Misleading Claims on Compounded Semaglutide, Tirzepatide Products Written By sheeba farhat22 Jun 2026 5:24 PM ISTBengaluru: The U.S. Food and Drug Administration issued 25 warning letters to telehealth companies for marketing false and misleading claims about...
Which GLP-1 medication is most effective for weight loss? Written By Dr Kartikeya Kohli22 Jun 2026 11:00 AM ISTGLP-1 medications are marketed to help you lose weight, but one may be better at it than the rest, according to a new meta-analysis from the...
Mounjaro Beats Ozempic-Class Drugs in Early Type 2 Diabetes Trial Written By sheeba farhat1 Jun 2026 10:52 PM ISTLondon: Recently diagnosed type 2 diabetes patients who did not respond well to a usual first-line treatment fared better after adding Eli Lilly's...
